Effects of continuous positive airways pressure (CPAP) therapy on cardiovascular risk factors in type 2 diabetic patients with newly-diagnosed sleep apnoea

Not Applicable

Recruiting

• Conditions: Type 2 diabetes; Sleep apnoea; Metabolic and Endocrine - Diabetes; Respiratory - Sleep apnoea

• Registration Number: ACTRN12609000419268
• Lead Sponsor: School of Medicine and Pharmacology, University of Western Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-06-09
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients with type 2 diabetes aged at least 18 years of either gender who screen positive for sleep apnoea by ApneaLink overnight study and Berlin questionnaire

Exclusion Criteria

Already on CPAP or previous trial of CPAP therapy unsuccessful or not tolerated

Study & Design

• Study Type: Interventional
• Study Design: Not specified